StudyRareStudyRare

Von Willebrand disease

Log in to star

Last updated Nov 3, 2026

Log in to add personal notes on this page.

A teenage girl has heavy menstrual bleeding and easy bruising. She also has prolonged bleeding after dental extraction. Both PTT and bleeding time are mildly prolonged.

AD (types 1, 2A, 2B, 2M) or AR (types 2N and 3); VWF, encoding von Willebrand factor. Loss of function in every type except 2B, which is a gain of function.

Types:

  • Type 1 (70-80%): Partial quantitative deficiency, mild
  • Type 2: Qualitative defects. Subtypes 2A, 2B, and 2M are typically AD; 2N (Normandy) disrupts the VWF binding site for factor VIII and is AR, producing a hemophilia-A-like picture (low factor VIII with normal VWF antigen)
  • Type 3: Severe quantitative deficiency, AR

Von Willebrand factor has two jobs: it binds the subendothelium at sites of vessel damage and recruits platelets, and it protects factor VIII from degradation in the circulation and carries it to sites of clotting. Endothelial cells and megakaryocytes assemble it into disulfide-linked multimers of up to 40 dimers, and a protease encoded by ADAMTS13 trims large multimers after secretion. Types 1 and 3 are partial and complete quantitative deficiencies; the type 2 subtypes are qualitative defects.

  • Type 1: partial quantitative deficiency, mostly from missense variants. In type 1C, missense variants in the D3 and A1 domains (most often p.Arg1205His, Vicenza) shorten the time the protein stays in plasma.
  • Type 2A: missense variants impair dimer or multimer assembly, increase cleavage by the protease, or trap the protein inside the cell; all lose the high-molecular-weight forms.
  • Type 2B: gain of function. The protein binds platelet GpIbα spontaneously, the complexes are cleared, and up to 50% develop mild-to-moderate thrombocytopenia.
  • Type 2M: poor binding to GpIbα with normal multimers.
  • Type 2N: reduced affinity for factor VIII.
  • Type 3: two null or missense alleles prevent secretion.
  • Most common inherited bleeding disorder
  • Mucocutaneous bleeding (epistaxis, menorrhagia, GI)
  • VWF carries factor VIII (low VWF → low VIII)
  • Prolonged bleeding time, may have prolonged PTT
  • Initial panel: VWF antigen (quantity), ristocetin cofactor activity (function), and factor VIII level
  • VWF multimer analysis distinguishes subtypes (loss of high-molecular-weight multimers in types 2A and 2B)
  • Ristocetin-induced platelet aggregation (RIPA): increased response at low ristocetin concentrations suggests type 2B
  • Confirmatory VWF molecular testing helps subtype classification and family testing
  • Desmopressin (DDAVP) for types 1 and some type 2, VWF concentrate

VWD is the only common AD bleeding disorder: Clotting/bleeding disorders that predispose to bleeding are mostly AR or XLR. VWD is the exception as the most common inherited bleeding disorder, with the major types (1, 2A, 2B, 2M) inherited AD. The recessive types are 2N and 3.

VWF stabilizes factor VIII: Low VWF leads to low factor VIII, which is why VWD can mimic hemophilia A on lab testing (prolonged PTT). VWF also mediates platelet adhesion via glycoprotein 1b.

Reference Links